Armstrong, April W, Sang Hee Park, Viktor Chirikov, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, and Vardhaman Patel. “Optimizing the Treatment Sequence: The Cumulative Clinical Benefit of Treatment Initiation With Deucravacitinib Versus Apremilast over 52 Weeks in Patients With Moderate to Severe Plaque Psoriasis from the POETYK PSO-1 Trial”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s62. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/1817.